Discovery of epilepsy treatment drug from spider venom peptides.
ソフィオンバイオサイエンス
Our company is jointly developing a new protocol that enables efficient screening studies to identify modulators of Kv7.2/Kv7.3 channel activity using spider venom peptides. This will advance the understanding of gain-of-function mutations in channel-related epilepsy and potential therapies. For more details, please see the related links.
